Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2024-07-23 00:00:00 ET · period of report 2024-07-19 · accession 0001140361-24-033783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-23 | 2024-07-19 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $7.18 | -1,025 | 64.3K | -2% | -$7,360 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-19 | F | D | 1,025 | $7.18 | 64,341 | D | — | — | (F1) The exempt disposition of 1,025 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023. |